Trial Profile
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Adding Methotrexate to Etanercept in Subjects With Moderate to Severe Plaque Psoriasis.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Etanercept (Primary) ; Methotrexate (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- Sponsors Amgen
- 20 Mar 2012 Results presented at the 70th Annual Meeting of the American Academy of Dermatology.
- 17 Feb 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 17 Feb 2011 Actual end date (Feb 2011) added as reported by ClinicalTrials.gov.